Portfolio (Quarterly)
Guide ↗
Jones Hill Capital LP
· CIK 0002102314| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 1,268,390.0 | $71.7M | 15.36% | NEW | — | $56.49 | -4.2% |
| 2 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 108,603.0 | $48.5M | 10.40% | NEW | — | $446.54 | -2.7% |
| 3 | PCVX | VAXCYTE INC | Healthcare | 644,831.0 | $37.5M | 8.03% | NEW | — | $58.11 | -18.6% |
| 4 | NUVL | NUVALENT INC | Healthcare | 300,830.0 | $30.8M | 6.61% | NEW | — | $102.45 | -0.3% |
| 5 | CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | 909,207.0 | $27.6M | 5.92% | NEW | — | $30.40 | -5.0% |
| 6 | TERN | TERNS PHARMACEUTICALS INC | Healthcare | 521,237.0 | $27.5M | 5.89% | NEW | — | $52.72 | +0.4% |
| 7 | BCAX | BICARA THERAPEUTICS INC | Healthcare | 1,260,136.0 | $25.1M | 5.37% | NEW | — | $19.89 | +9.0% |
| 8 | ANIP | ANI PHARMACEUTICALS INC | Healthcare | 318,591.0 | $24.5M | 5.25% | NEW | — | $76.90 | +7.6% |
| 9 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1,165,557.0 | $24.4M | 5.24% | NEW | — | $20.95 | +11.6% |
| 10 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 593,040.0 | $23.2M | 4.98% | NEW | — | $39.20 | +6.0% |
| 11 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 1,598,794.0 | $22.2M | 4.76% | NEW | — | $13.90 | -2.3% |
| 12 | ARGX | ARGENX SE | Healthcare | 25,995.0 | $19.0M | 4.07% | NEW | — | $730.25 | +10.4% |
| 13 | FULC | FULCRUM THERAPEUTICS INC | Healthcare | 1,771,926.0 | $13.6M | 2.91% | NEW | — | $7.67 | -14.3% |
| 14 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 1,198,213.0 | $10.7M | 2.30% | NEW | — | $8.96 | +2.6% |
| 15 | NUVB | NUVATION BIO INC | Healthcare | 2,383,031.0 | $10.2M | 2.19% | NEW | — | $4.29 | +10.0% |
| 16 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 140,843.0 | $6.9M | 1.48% | NEW | — | $49.05 | +23.6% |
| 17 | CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | 513,053.0 | $6.7M | 1.44% | NEW | — | $13.06 | +6.1% |
| 18 | MANE | VERADERMICS INC | Healthcare | 100,843.0 | $6.4M | 1.36% | NEW | — | $63.15 | +60.9% |
| 19 | TNXP | TONIX PHARMACEUTICALS HLDG C | Healthcare | 452,116.0 | $6.2M | 1.33% | NEW | — | $13.75 | -7.1% |
| 20 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 100,593.0 | $4.8M | 1.04% | NEW | — | $48.20 | -18.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%